CytomX Therapeutics Gross Loans (Quarterly) Analysis

CytomX Therapeutics, Inc. (CTMX)

5.44 -0.14 (-2.51%) USD | NASDAQ | Feb 24, 16:00

5.47 +0.03 (+0.55%) After-Hours: 06:30

View Gross Loans (Quarterly) for CTMX.
Upgrade now.

Sep '18

Jan '19

May '19

285.00

270.00

255.00

240.00

View Gross Loans (Quarterly) Chart

Start Trial

View Historical Data

Start Trial

View Gross Loans (Quarterly) Range, Past 5 Years

Start Trial

Minimum

Maximum

Average

Median

View Gross Loans (Quarterly) Benchmarks

Start Trial

REGENXBIO, Inc.	--
ACADIA Pharmaceuticals, Inc.	--
Alnylam Pharmaceuticals, Inc.	--
Savara, Inc.	--
BioMarin Pharmaceutical, Inc.	--